{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:18:42Z","timestamp":1793146722896,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Military Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Most sepsis patients develop sepsis-associated acute kidney injury (SA-AKI), which poses a significant threat to survival and lacks specific treatment. To date, there are no published randomized controlled trials that have established a link between albumin use and SA-AKI development in sepsis. Therefore, it is unclear whether albumin use may influence the risk of SA-AKI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The present study employed a target trial emulation using observational data to track adult sepsis patients initially admitted to the intensive care unit at Beth Israel Deaconess Medical Center, Boston, Massachusetts, for a period of 7 d from 2008 to 2022. Immortal time bias was controlled using the clone-censor-weight (CCW) method, along with a new-user design to address current user bias. The exposure variable was the early administration of albumin following the onset of sepsis. Based on albumin use, patients were classified into two groups: the albumin group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927,088) and the no albumin group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927,088). The primary outcome was the development of SA-AKI, and the secondary outcome was 7-day all-cause mortality. The primary outcome was analyzed using competing risk analyses. Furthermore, sensitivity and subgroup analyses were also performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 27,088 patients analyzed, albumin administration was associated with a significantly higher SA-AKI risk (relative difference\u2009=\u20093.47%, 95% CI 1.76\u22125.23) compared to non-administration. There was no clinically meaningful difference in 7-day survival (relative difference\u2009=\u20090.05%, 95% CI \u22122.30 to 2.45). Sensitivity analyses consistently supported these results. All these analyses were conducted on data that were collected after CCW.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early albumin administration may increase the risk of SA-AKI in sepsis patients without conferring a short-term survival benefit. These results underscore the need for a rigorous risk-benefit assessment when incorporating albumin into sepsis resuscitation protocols and highlight the need for further clinical validation. However, it is important to exercise caution when interpreting the conclusions of this study, given its exploratory and preliminary nature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40779-025-00641-z","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T06:58:59Z","timestamp":1755759539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Early use of albumin may increase the risk of sepsis-associated acute kidney injury in sepsis patients: a target trial emulation"],"prefix":"10.1016","volume":"12","author":[{"given":"Xin-Ya","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Kai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2237-8771","authenticated-orcid":false,"given":"Jun","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"7","key":"641_CR1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2215\/CJN.00850122","volume":"17","author":"S Kuwabara","year":"2022","unstructured":"Kuwabara S, Goggins E, Okusa MD. The pathophysiology of sepsis-associated AKI. Clin J Am Soc Nephrol. 2022;17(7):1050\u201369.","journal-title":"Clin J Am Soc Nephrol"},{"key":"641_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4891","volume":"364","author":"JT Poston","year":"2019","unstructured":"Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364:k4891.","journal-title":"BMJ"},{"issue":"5","key":"641_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana S, Manrique-Caballero CL, G\u00f3mez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083\u201399.","journal-title":"Kidney Int"},{"issue":"6","key":"641_CR4","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.jtha.2024.02.006","volume":"22","author":"T Iba","year":"2024","unstructured":"Iba T, Helms J, Maier CL, Levi M, Scarlatescu E, Levy JH. The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy. J Thromb Haemost. 2024;22(6):1530\u201340.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"641_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00134-023-07138-0","volume":"49","author":"KC White","year":"2023","unstructured":"White KC, Serpa-Neto A, Hurford R, Clement P, Laupland KB, See E, et al. Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med. 2023;49(9):1079\u201389.","journal-title":"Intensive Care Med"},{"issue":"1","key":"641_CR6","volume":"11","author":"T Gong","year":"2024","unstructured":"Gong T, Liu YT, Fan J. Exosomal mediators in sepsis and inflammatory organ injury: unraveling the role of exosomes in intercellular crosstalk and organ dysfunction. Mil Med Res. 2024;11(1):24.","journal-title":"Mil Med Res"},{"issue":"6","key":"641_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","volume":"19","author":"A Zarbock","year":"2023","unstructured":"Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, et al. Sepsis-associated acute kidney injury: consensus report of the 28th acute disease quality initiative workgroup. Nat Rev Nephrol. 2023;19(6):401\u201317.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"641_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.52314","volume":"7","author":"S Tingsg\u00e5rd","year":"2024","unstructured":"Tingsg\u00e5rd S, Bastrup Israelsen S, J\u00f8rgensen HL, \u00d8stergaard C, Benfield T. Early switch from intravenous to oral antibiotics for patients with uncomplicated gram-negative bacteremia. JAMA Netw Open. 2024;7(1):e2352314.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"641_CR9","doi-asserted-by":"publisher","first-page":"1667\u22129","DOI":"10.1097\/01.CCM.0000170175.18540.CD","volume":"33","author":"GS Martin","year":"2005","unstructured":"Martin GS. Pharmacological aspects of albumin as a niche product in the intensive care unit. Crit Care Med. 2005;33(7):1667\u20139.","journal-title":"Crit Care Med"},{"issue":"7","key":"641_CR10","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1093\/ndt\/gfac279","volume":"38","author":"T Mayerh\u00f6fer","year":"2022","unstructured":"Mayerh\u00f6fer T, Shaw AD, Wiedermann CJ, Joannidis M. Fluids in the ICU: which is the right one?. Nephrol Dial Transplant. 2022;38(7):1603\u201312.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"641_CR11","first-page":"588","volume":"20","author":"A Zarbock","year":"2014","unstructured":"Zarbock A, Gomez H, Kellum JA. Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies. Curr Opin Crit Care. 2014;20(6):588\u201395.","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"641_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.kint.2016.07.032","volume":"91","author":"EH Post","year":"2017","unstructured":"Post EH, Kellum JA, Bellomo R, Vincent JL. Renal perfusion in sepsis: from macro- to microcirculation. Kidney Int. 2017;91(1):45\u201360.","journal-title":"Kidney Int"},{"key":"641_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071108","volume":"378","author":"AA Matthews","year":"2022","unstructured":"Matthews AA, Danaei G, Islam N, Kurth T. Target trial emulation: applying principles of randomised trials to observational studies. BMJ. 2022;378:e071108.","journal-title":"BMJ"},{"issue":"24","key":"641_CR14","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n MA, Wang W, Leaf DE. Target trial emulation: a framework for causal inference from observational data. JAMA. 2022;328(24):2446\u20137.","journal-title":"JAMA"},{"key":"641_CR15","doi-asserted-by":"publisher","first-page":"k182","DOI":"10.1136\/bmj.k182","volume":"360","author":"MA Hern\u00e1n","year":"2018","unstructured":"Hern\u00e1n MA. How to estimate the effect of treatment duration on survival outcomes using observational data. BMJ. 2018;360:k182. https:\/\/doi.org\/10.1136\/bmj.k182.","journal-title":"BMJ"},{"issue":"8","key":"641_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"4","key":"641_CR17","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. Kdigo clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384.","journal-title":"Nephron Clin Pract"},{"issue":"9596","key":"641_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"issue":"1","key":"641_CR19","volume":"10","author":"WQ Che","year":"2023","unstructured":"Che WQ, Li YJ, Tsang CK, Wang YJ, Chen Z, Wang XY, et al. How to use the surveillance, epidemiology, and end results (SEER) data: research design and methodology. Mil Med Res. 2023;10(1):50.","journal-title":"Mil Med Res"},{"issue":"1","key":"641_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1.","journal-title":"Sci Data"},{"issue":"3","key":"641_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/jebm.12548","volume":"16","author":"Y Xu","year":"2023","unstructured":"Xu Y, Zheng X, Li Y, Ye X, Cheng H, Wang H, et al. Exploring patient medication adherence and data mining methods in clinical big data: a contemporary review. J Evid Based Med. 2023;16(3):342\u201375.","journal-title":"J Evid Based Med"},{"key":"641_CR22","doi-asserted-by":"publisher","unstructured":"Johnson A, Bulgarelli L, Pollard T, Gow B, Moody B, Horng S, et al. MIMIC-IV (version 3.0). PhysioNet. 2024. https:\/\/doi.org\/10.13026\/kpb9-mt58.","DOI":"10.13026\/kpb9-mt58"},{"issue":"8","key":"641_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758\u201364.","journal-title":"Am J Epidemiol"},{"issue":"23","key":"641_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70461","volume":"13","author":"CE Gaber","year":"2024","unstructured":"Gaber CE, Ghazarian AA, Strassle PD, Ribeiro TB, Salas M, Maringe C, et al. De-mystifying the clone-censor-weight method for causal research using observational data: a primer for cancer researchers. Cancer Med. 2024;13(23):e70461.","journal-title":"Cancer Med"},{"issue":"4","key":"641_CR25","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.chest.2024.10.012","volume":"167","author":"AE Patanwala","year":"2025","unstructured":"Patanwala AE, Flannery AH, Mehta HB, Hills TE, McArthur CJ, Erstad BL. Comparative effectiveness of albumin vs no albumin on renal replacement therapy and mortality in patients with septic shock and renal impairment. Chest. 2025;167(4):1090\u20138.","journal-title":"Chest"},{"issue":"10141","key":"641_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75\u201387.","journal-title":"Lancet"},{"issue":"10","key":"641_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108768","volume":"24","author":"EV Fot","year":"2023","unstructured":"Fot EV, Khromacheva NO, Ushakov AA, Smetkin AA, Kuzkov VV, Kirov MY. Optimizing fluid management guided by volumetric parameters in patients with sepsis and ARDS. Int J Mol Sci. 2023;24(10):8768.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"641_CR28","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/ije\/dyaa057","volume":"49","author":"C Maringe","year":"2020","unstructured":"Maringe C, Benitez Majano S, Exarchakou A, Exarchakou A, Smith M, Rachet B, et al. Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data. Int J Epidemiol. 2020;49(5):1719\u201329.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"641_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13613-021-00830-8","volume":"11","author":"S Zhou","year":"2021","unstructured":"Zhou S, Zeng Z, Wei H, Sha T, An S. Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database. Ann Intensive Care. 2021;11(1):42.","journal-title":"Ann Intensive Care"},{"issue":"7","key":"641_CR30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/djae024","volume":"116","author":"J Kirkeg\u00e5rd","year":"2024","unstructured":"Kirkeg\u00e5rd J, Gaber C, Heide-J\u00f8rgensen U, Fristrup CW, Lund JL, Cronin-Fenton D, et al. Effect of surgery versus chemotherapy in pancreatic cancer patients: a target trial emulation. J Natl Cancer Inst. 2024;116(7):1072\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"641_CR31","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/sim.8896","volume":"40","author":"SC Conner","year":"2021","unstructured":"Conner SC, Trinquart L. Estimation and modeling of the restricted mean time lost in the presence of competing risks. Stat Med. 2021;40(9):2177\u201396.","journal-title":"Stat Med"},{"issue":"21","key":"641_CR32","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1002\/sim.9495","volume":"41","author":"C Zhang","year":"2022","unstructured":"Zhang C, Huang B, Wu H, Yuan H, Hou Y, Chen Z. Restricted mean survival time regression model with time-dependent covariates. Stat Med. 2022;41(21):4081\u201390.","journal-title":"Stat Med"},{"issue":"4","key":"641_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10985-015-9335-y","volume":"21","author":"OO Aalen","year":"2015","unstructured":"Aalen OO, Cook RJ, R\u00f8ysland K. Does cox analysis of a randomized survival study yield a causal treatment effect? Lifetime Data Anal. 2015;21(4):579\u201393.","journal-title":"Lifetime Data Anal"},{"issue":"9","key":"641_CR34","first-page":"1322","volume":"37","author":"PC Austin","year":"2021","unstructured":"Austin PC, White IR, Lee DS, van Buuren S. Missing data in clinical research: a tutorial on multiple imputation. Can J Cardiol. 2021;37(9):1322\u201331.","journal-title":"Can J Cardiol"},{"issue":"1","key":"641_CR35","volume":"8","author":"WT Wu","year":"2021","unstructured":"Wu WT, Li YJ, Feng AZ, Li L, Huang T, Xu AD, et al. Data mining in clinical big data: the frequently used databases, steps, and methodological models. Mil Med Res. 2021;8(1):44.","journal-title":"Mil Med Res"},{"key":"641_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2022.110960","volume":"83","author":"H Hu","year":"2022","unstructured":"Hu H, An S, Sha T, Wu F, Jin Y, Li L, et al. Association between dexmedetomidine administration and outcomes in critically ill patients with sepsis-associated acute kidney injury. J Clin Anesth. 2022;83:110960.","journal-title":"J Clin Anesth"},{"issue":"2","key":"641_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1681\/ASN.2015030261","volume":"27","author":"H Rabb","year":"2016","unstructured":"Rabb H, Griffin MD, McKay DB, Swaminathan S, Pickkers P, Rosner MH, et al. Inflammation in AKI: current understanding, key questions, and knowledge gaps. J Am Soc Nephrol. 2016;27(2):371\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"641_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u201377.","journal-title":"Intensive Care Med"},{"issue":"1","key":"641_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00134-010-2039-6","volume":"37","author":"The SAFE Study Investigators","year":"2011","unstructured":"The SAFE Study Investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37(1):86\u201396.","journal-title":"Intensive Care Med"},{"key":"641_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcrc.2016.04.019","volume":"35","author":"JL Vincent","year":"2016","unstructured":"Vincent JL, De Backer D, Wiedermann CJ. Fluid management in sepsis: the potential beneficial effects of albumin. J Crit Care. 2016;35:161\u20137.","journal-title":"J Crit Care"},{"issue":"15","key":"641_CR41","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412\u201321.","journal-title":"N Engl J Med"},{"key":"641_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4561","volume":"349","author":"A Patel","year":"2014","unstructured":"Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561.","journal-title":"BMJ"},{"key":"641_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s13054-020-03419-y","volume":"24","author":"CH Tseng","year":"2020","unstructured":"Tseng CH, Chen TT, Wu MY, Chan MC, Shih MC, Tu YK. Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses. Crit Care. 2020;24:693.","journal-title":"Crit Care"},{"issue":"4","key":"641_CR44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2215\/CJN.00060110","volume":"5","author":"RW Schrier","year":"2010","unstructured":"Schrier RW. Fluid administration in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2010;5(4):733\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"641_CR45","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1097\/SLA.0000000000005774","volume":"278","author":"DV Lazzareschi","year":"2023","unstructured":"Lazzareschi DV, Fong N, Mavrothalassitis O, et al. Intraoperative use of albumin in major noncardiac surgery: incidence, variability, and association with outcomes. Ann Surg. 2023;278(4):e745\u201353.","journal-title":"Ann Surg"},{"issue":"12","key":"641_CR46","volume":"4","author":"K Raghunathan","year":"2022","unstructured":"Raghunathan K, Kempker JA, Davis EA, Sindhwani NS, Telang S, Lodaya K, et al. Early albumin infusion is associated with greater survival to discharge among patients with sepsis\/septic shock who develop severe acute kidney injury among patients with sepsis\/septic shock who develop severe acute kidney injury. Crit Care Explor. 2022;4(12):e0793.","journal-title":"Crit Care Explor"},{"key":"641_CR47","doi-asserted-by":"publisher","first-page":"24083","DOI":"10.1038\/s41598-021-03122-0","volume":"11","author":"C Ge","year":"2021","unstructured":"Ge C, Peng Q, Chen W, Li W, Zhang L, Ai Y. Association between albumin infusion and outcomes in patients with acute kidney injury and septic shock. Sci Rep. 2021;11:24083.","journal-title":"Sci Rep"},{"issue":"6","key":"641_CR48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00134-024-07369-9","volume":"50","author":"YM Arabi","year":"2024","unstructured":"Arabi YM, Belley-Cote E, Carsetti A, De Backer D, Donadello K, Juffermans NP, et al. European society of intensive care medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids. Intensive Care Med. 2024;50(6):813\u201331.","journal-title":"Intensive Care Med"},{"issue":"11","key":"641_CR49","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-025-00641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40779-025-00641-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-025-00641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:53:09Z","timestamp":1772830389000},"score":1,"resource":{"primary":{"URL":"https:\/\/mmrjournal.biomedcentral.com\/articles\/10.1186\/s40779-025-00641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1186\/s40779-025-00641-z","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Information Mart for Intensive Care IV (MIMIC-IV) database was supported by grants from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH) under award numbers R01-EB001659 (2003\u20132013) and R01-EB017205 (2014\u20132018), and approved by the Institutional Review Boards of Beth Israel Deaconess Medical Center (Boston, MA) and the Massachusetts Institute of Technology (Cambridge, MA).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}